Detection of SMARCB1 loss in ascites cells in the diagnosis of an abdominal rhabdoid tumor

Standard

Detection of SMARCB1 loss in ascites cells in the diagnosis of an abdominal rhabdoid tumor. / Kerl, Kornelius; Oyen, Florian; Leuschner, Ivo; Schneppenheim, Reinhard; Nagel, Inga; Siebert, Reiner; Groll, Andreas H; Hartmann, Wolfgang; Barth, Peter Josef; Bartelheim, Kerstin; Seringer, Angela; Wardelmann, Eva; Frühwald, Michael C.

In: PEDIATR BLOOD CANCER, Vol. 62, No. 5, 05.2015, p. 897-900.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Kerl, K, Oyen, F, Leuschner, I, Schneppenheim, R, Nagel, I, Siebert, R, Groll, AH, Hartmann, W, Barth, PJ, Bartelheim, K, Seringer, A, Wardelmann, E & Frühwald, MC 2015, 'Detection of SMARCB1 loss in ascites cells in the diagnosis of an abdominal rhabdoid tumor', PEDIATR BLOOD CANCER, vol. 62, no. 5, pp. 897-900. https://doi.org/10.1002/pbc.25412

APA

Kerl, K., Oyen, F., Leuschner, I., Schneppenheim, R., Nagel, I., Siebert, R., Groll, A. H., Hartmann, W., Barth, P. J., Bartelheim, K., Seringer, A., Wardelmann, E., & Frühwald, M. C. (2015). Detection of SMARCB1 loss in ascites cells in the diagnosis of an abdominal rhabdoid tumor. PEDIATR BLOOD CANCER, 62(5), 897-900. https://doi.org/10.1002/pbc.25412

Vancouver

Kerl K, Oyen F, Leuschner I, Schneppenheim R, Nagel I, Siebert R et al. Detection of SMARCB1 loss in ascites cells in the diagnosis of an abdominal rhabdoid tumor. PEDIATR BLOOD CANCER. 2015 May;62(5):897-900. https://doi.org/10.1002/pbc.25412

Bibtex

@article{ce83b0443b0a4491b23e2220f76d302c,
title = "Detection of SMARCB1 loss in ascites cells in the diagnosis of an abdominal rhabdoid tumor",
abstract = "We report on how MLPA and Sequencing of SMARCB1/INI1/SNF5 might be applied for initial diagnosis of rhabdoid tumor patients. These techniques were successfully used to detect loss of SMARCB1 in tumor cells of the ascites in a 3-month-old patient in which tumor biopsy could not initially be made due to life threatening intraabdominal bleedings. Pediatr Blood Cancer 2015;62:897-900. {\textcopyright} 2015 Wiley Periodicals, Inc.",
author = "Kornelius Kerl and Florian Oyen and Ivo Leuschner and Reinhard Schneppenheim and Inga Nagel and Reiner Siebert and Groll, {Andreas H} and Wolfgang Hartmann and Barth, {Peter Josef} and Kerstin Bartelheim and Angela Seringer and Eva Wardelmann and Fr{\"u}hwald, {Michael C}",
note = "{\textcopyright} 2015 Wiley Periodicals, Inc.",
year = "2015",
month = may,
doi = "10.1002/pbc.25412",
language = "English",
volume = "62",
pages = "897--900",
journal = "PEDIATR BLOOD CANCER",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "5",

}

RIS

TY - JOUR

T1 - Detection of SMARCB1 loss in ascites cells in the diagnosis of an abdominal rhabdoid tumor

AU - Kerl, Kornelius

AU - Oyen, Florian

AU - Leuschner, Ivo

AU - Schneppenheim, Reinhard

AU - Nagel, Inga

AU - Siebert, Reiner

AU - Groll, Andreas H

AU - Hartmann, Wolfgang

AU - Barth, Peter Josef

AU - Bartelheim, Kerstin

AU - Seringer, Angela

AU - Wardelmann, Eva

AU - Frühwald, Michael C

N1 - © 2015 Wiley Periodicals, Inc.

PY - 2015/5

Y1 - 2015/5

N2 - We report on how MLPA and Sequencing of SMARCB1/INI1/SNF5 might be applied for initial diagnosis of rhabdoid tumor patients. These techniques were successfully used to detect loss of SMARCB1 in tumor cells of the ascites in a 3-month-old patient in which tumor biopsy could not initially be made due to life threatening intraabdominal bleedings. Pediatr Blood Cancer 2015;62:897-900. © 2015 Wiley Periodicals, Inc.

AB - We report on how MLPA and Sequencing of SMARCB1/INI1/SNF5 might be applied for initial diagnosis of rhabdoid tumor patients. These techniques were successfully used to detect loss of SMARCB1 in tumor cells of the ascites in a 3-month-old patient in which tumor biopsy could not initially be made due to life threatening intraabdominal bleedings. Pediatr Blood Cancer 2015;62:897-900. © 2015 Wiley Periodicals, Inc.

U2 - 10.1002/pbc.25412

DO - 10.1002/pbc.25412

M3 - SCORING: Journal article

C2 - 25663425

VL - 62

SP - 897

EP - 900

JO - PEDIATR BLOOD CANCER

JF - PEDIATR BLOOD CANCER

SN - 1545-5009

IS - 5

ER -